FDA Review of Mifepristone Sparks Debate

HHS Secretary Robert F. Kennedy Jr. launched FDA review of mifepristone.
National Right to Life urged FDA to tighten controls citing non-peer-reviewed study.
Mifepristone and misoprostol are 97% effective with underreported complications.
Texas allows private citizens to sue suppliers for $100,000 over abortion drugs.
Ken Paxton sent cease-and-desist letters to groups shipping abortion drugs.

Science | Health Policy | Political Pressure

United States | Texas

Robert F. Kennedy Jr. | Ken Paxton | FDA Commissioner Marty Makary | Freedman

3 months ago